Breast Cancer Trial, Not Yet Recruiting NCT07253168 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07253168
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women aged 18 or older who have been diagnosed with breast cancer that has not spread to other parts of the body and who are scheduled to have surgery.
  • There must be enough tumor tissue and nearby normal tissue left over after standard diagnostic testing to be used for research.
  • The person must be willing and able to give written consent to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have an active infection throughout the body or a fever above 38.0°C in the 72 hours before surgery.
  • People who have taken antibiotics in the 14 days before tissue collection (confirm with trial site, as this may be recorded and accounted for in the analysis rather than being an automatic exclusion).
  • People who have already had surgery on the same breast for the current cancer, unless the new surgery involves fresh tissue being removed as a re-excision.
  • People who have any condition that would prevent them from being able to follow the study's requirements.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Brunella Posteraro, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +3906030157959

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 December 2027

Primary endpoints

Breast cancer-associated microbial signatures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov